Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/54227
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Callejas, Nuria A. | |
dc.contributor.author | Castrillo, Antonio | |
dc.contributor.author | Boscá, Lisardo | |
dc.contributor.author | Martín-Sanz, Paloma | |
dc.date.accessioned | 2019-02-18T09:26:02Z | - |
dc.date.available | 2019-02-18T09:26:02Z | - |
dc.date.issued | 1999 | |
dc.identifier.issn | 0022-3565 | |
dc.identifier.uri | http://hdl.handle.net/10553/54227 | - |
dc.publisher | 0022-3565 | |
dc.relation.ispartof | Journal of Pharmacology and Experimental Therapeutics | |
dc.source | Journal of Pharmacology and Experimental Therapeutics[ISSN 0022-3565],v. 288, p. 1235-1241 | |
dc.title | Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators | |
dc.type | info:eu-repo/semantics/article | |
dc.type | Article | |
dc.identifier.scopus | 0033021515 | |
dc.contributor.authorscopusid | 6602839757 | |
dc.contributor.authorscopusid | 55445301000 | |
dc.contributor.authorscopusid | 35514045400 | |
dc.contributor.authorscopusid | 57196054763 | |
dc.description.lastpage | 1241 | |
dc.description.firstpage | 1235 | |
dc.relation.volume | 288 | |
dc.type2 | Artículo | |
dc.identifier.ulpgc | Sí | es |
dc.description.jcr | 3,3 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.orcid | 0000-0002-2057-2159 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Castrillo Viguera, Antonio Jesús | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
53
checked on Nov 17, 2024
Page view(s)
65
checked on Mar 9, 2024
Google ScholarTM
Check
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.